牛叉诊股

[{"date":"2026.09.03","stock":"-1.78","trade":"-0.47","ind":"0.10"},{"date":"2026.09.02","stock":"-5.69","trade":"-1.10","ind":"-1.88"},{"date":"2026.09.01","stock":"1.50","trade":"1.18","ind":"-1.02"},{"date":"2026.08.31","stock":"13.42","trade":"-1.47","ind":"0.44"},{"date":"2026.08.28","stock":"-0.31","trade":"-0.76","ind":"-0.68"},{"date":"2026.08.27","stock":"0.31","trade":"1.37","ind":"1.50"},{"date":"2026.08.26","stock":"-0.77","trade":"0.02","ind":"0.69"},{"date":"2026.08.25","stock":"2.75","trade":"2.42","ind":"-0.35"},{"date":"2026.08.24","stock":"-1.32","trade":"-2.88","ind":"-2.13"},{"date":"2026.08.21","stock":"-1.90","trade":"-3.66","ind":"0.87"},{"date":"2026.08.20","stock":"4.53","trade":"3.82","ind":"0.59"},{"date":"2026.08.19","stock":"-2.41","trade":"-2.08","ind":"-5.01"},{"date":"2026.08.18","stock":"-1.75","trade":"-0.60","ind":"-0.56"},{"date":"2026.08.17","stock":"1.79","trade":"0.71","ind":"2.44"},{"date":"2026.08.14","stock":"-0.16","trade":"-0.46","ind":"0.45"},{"date":"2026.08.13","stock":"-0.62","trade":"1.38","ind":"-0.87"},{"date":"2026.08.12","stock":"0.85","trade":"0.65","ind":"1.09"},{"date":"2026.08.11","stock":"-1.23","trade":"0.17","ind":"-0.40"},{"date":"2026.08.10","stock":"2.12","trade":"1.23","ind":"0.04"},{"date":"2026.08.07","stock":"3.49","trade":"4.40","ind":"1.42"},{"date":"2026.08.06","stock":"1.40","trade":"0.12","ind":"-0.24"}]

赛托生物,深证成指,化学制药指数

压力支撑

该股压力位为13.96元，支撑位为13.65元。

[{"text":"\u538b\u529b\u4f4d","value":"13.96","date":1788364800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"13.65","date":1788364800,"color":"0x0b52a1"}]

多空趋势

空头行情中，目前正处于反弹阶段，投资者可适当关注。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：4.6资金面打败了87%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力没有控盘。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

化学制药行业，近5日资金流出较多，不建议投资者关注该行业的个股。

更新时间：09月03日 20:30

机构今日流向(万元)	-689.87	机构5日流向(万元)	-6792.33
机构10日流向(万元)	-15303.40	机构20日流向(万元)	-21462.69

机构持仓

2026-06-30 与 2025-12-31 相比，主力机构持仓量增加582.87万股，其中基金净增仓2家，主力净增仓55家，有一定的中长期投资价值。

截止2026-06-30，共103家主力机构（基金101家，QFII1家，一般法人1家），持仓量总计5204.79万股，占流通A股27.96%
其中，基金持仓与2025-12-31相比：
增仓：8家，增持 19.58万股
减仓：6家，减持 26.96万股
新出现在主力名单中：86家，持有651.29万股
从主力名单中消失：31家，原持有61.04万股

消息面诊股

诊断结果：5.5消息面打败了33%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	分红转增	不分配不转增	2026-08-29
一般消息	高管变动	个人原因	2026-07-22
一般消息	募资投向		2026-06-05
一般消息	股东大会	年度股东大会	2026-05-12
利好	分红转增	10派0.050637元(含税)	2026-04-28
利好	业绩预告	预计减亏	2026-01-30
一般消息	重大事项	关联交易	2026-01-16
一般消息	重大事项	公司股东股份解押	2025-12-26
一般消息	高管变动	取消监事会	2025-09-12

一年消息统计

	所有消息	重大消息	非重大消息
利好	2条	0条	2条
利空	0条	0条	0条

行业面诊股

诊断结果：2.1行业面打败了18%的股票化学制药行业最新资金流向

近10日来该行业走势总体向下，跑输大盘。

行业面得分最高的股票

行业走势

近10日来该行业走势总体向下，跑输大盘。

[{"date":"2026.09.03","price":"0.10","value":"-0.47"},{"date":"2026.09.02","price":"-1.88","value":"-1.10"},{"date":"2026.09.01","price":"-1.02","value":"1.18"},{"date":"2026.08.31","price":"0.44","value":"-1.47"},{"date":"2026.08.28","price":"-0.68","value":"-0.76"},{"date":"2026.08.27","price":"1.50","value":"1.37"},{"date":"2026.08.26","price":"0.69","value":"0.02"},{"date":"2026.08.25","price":"-0.35","value":"2.42"},{"date":"2026.08.24","price":"-2.13","value":"-2.88"},{"date":"2026.08.21","price":"0.87","value":"-3.66"},{"date":"2026.08.20","price":"0.59","value":"3.82"},{"date":"2026.08.19","price":"-5.01","value":"-2.08"},{"date":"2026.08.18","price":"-0.56","value":"-0.60"},{"date":"2026.08.17","price":"2.44","value":"0.71"},{"date":"2026.08.14","price":"0.45","value":"-0.46"},{"date":"2026.08.13","price":"-0.87","value":"1.38"},{"date":"2026.08.12","price":"1.09","value":"0.65"},{"date":"2026.08.11","price":"-0.40","value":"0.17"},{"date":"2026.08.10","price":"0.04","value":"1.23"},{"date":"2026.08.07","price":"1.42","value":"4.40"},{"date":"2026.08.06","price":"-0.24","value":"0.12"}]

深证成指,化学制药行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	神奇制药	81.80%	-21.71%	5.4分
2	誉衡药业	49.65%	-3.85%	5.1分
3	哈药股份	37.46%	-2.29%	5.8分
4	东亚药业	36.97%	13.70%	4.5分
5	科源制药	24.35%	2.48%	5.5分
6	键凯科技	22.02%	-34.63%	4.2分
7	-	21.23%	6.29%	分
8	冀衡医药	20.80%	-20.11%	4.8分
9	盟科药业	18.35%	-0.52%	5.2分
10	ST复华	17.42%	9.15%	5.3分
11	小方制药	15.33%	10.19%	4.9分
12	迪哲医药	14.57%	2.61%	5.2分
13	永安药业	13.79%	-1.67%	5.1分
14	西点药业	13.68%	-22.07%	4.2分
15	花园生物	13.37%	2.11%	4.9分
16	海森药业	12.67%	0.93%	5.2分
17	-	12.18%	-2.19%	分
18	赛托生物	12.17%	6.30%	5.4分
19	汉商集团	11.95%	0.92%	5.7分
20	中关村	11.74%	-19.82%	4.9分
21	丰原药业	11.51%	-3.88%	5.4分
22	-	11.10%	0.40%	分
23	多瑞医药	10.90%	8.37%	5.2分
24	莱美药业	10.89%	-9.54%	4.5分
25	石药创新	10.60%	-5.77%	5.4分
26	ST天圣	10.15%	-1.37%	5.2分
27	德展健康	9.73%	6.49%	5.1分
28	华纳药厂	9.64%	6.56%	6.0分
29	莎普爱思	9.53%	-2.01%	5.0分
30	-	9.36%	5.27%	分
31	中哲精化	9.07%	0.82%	5.4分
32	海欣股份	8.96%	-0.80%	4.3分
33	-	8.49%	4.71%	分
34	广济药业	8.33%	-4.21%	5.3分
35	复旦张江	8.09%	-3.84%	4.6分
36	凯因科技	7.92%	-3.54%	4.2分
37	亨迪药业	7.76%	-8.94%	4.4分
38	ST能特	7.11%	3.43%	6.0分
39	本立科技	6.96%	0.20%	5.5分
40	悦康药业	6.57%	-14.18%	4.1分
41	浙江医药	6.27%	-2.31%	4.8分
42	汇宇制药	6.23%	-1.09%	4.9分
43	ST人福	6.06%	2.38%	5.7分
44	宣泰医药	6.06%	-6.95%	4.7分
45	福安药业	5.96%	-2.98%	4.9分
46	北陆药业	5.90%	-9.84%	5.0分
47	金石亚药	5.70%	-5.52%	5.0分
48	恩华药业	5.46%	2.63%	5.8分
49	华仁药业	5.22%	-3.42%	4.9分
50	上海谊众	5.16%	-5.34%	4.4分
51	威尔药业	5.01%	-0.19%	4.4分
52	山河药辅	4.96%	-0.31%	4.3分
53	北大医药	4.95%	-4.34%	4.8分
54	益方生物	4.89%	-2.54%	5.1分
55	尔康制药	4.81%	-4.39%	4.7分
56	东北制药	4.80%	-6.25%	4.7分
57	双鹭药业	4.75%	-9.15%	4.6分
58	仟源医药	4.70%	-5.65%	5.4分
59	亚太药业	4.68%	-4.11%	4.4分
60	泽璟制药	4.59%	-1.95%	5.3分
61	赛分科技	4.37%	3.39%	6.0分
62	吉贝尔	4.36%	0.75%	5.0分
63	天新药业	4.35%	6.87%	5.5分
64	美诺华	4.02%	5.13%	5.0分
65	金陵药业	3.94%	-3.37%	4.7分
66	-	3.75%	4.97%	分
67	ST南新	3.39%	0.15%	4.4分
68	鲁抗医药	2.99%	1.47%	5.1分
69	仙琚制药	2.96%	1.04%	6.1分
70	天宇股份	2.76%	-0.05%	4.5分
71	ST诺泰	2.76%	2.61%	5.0分
72	向日葵	2.68%	-1.29%	4.1分
73	富士莱	2.67%	-1.49%	4.6分
74	富祥股份	2.64%	9.30%	5.8分
75	亚虹医药	2.50%	6.53%	4.8分
76	卫信康	2.36%	-2.67%	4.8分
77	奥翔药业	2.07%	-1.86%	4.1分
78	海普瑞	2.06%	-6.70%	4.6分
79	立方制药	2.05%	-4.59%	5.7分
80	润都股份	1.85%	-0.54%	5.0分
81	ST惠程	1.62%	-2.58%	5.1分
82	翰宇药业	1.60%	-2.14%	5.5分
83	哈三联	1.47%	-10.51%	4.0分
84	海思科	1.40%	1.81%	6.3分
85	华邦健康	1.37%	-2.85%	5.1分
86	海翔药业	1.33%	2.50%	5.2分
87	民生健康	1.07%	-4.42%	4.8分
88	普洛药业	1.03%	-0.19%	6.1分
89	艾力斯	0.87%	-2.94%	5.6分
90	同和药业	0.73%	-1.01%	4.6分
91	九典制药	0.73%	-3.93%	4.5分
92	必贝特	0.65%	-9.06%	4.8分
93	首药控股	0.64%	-5.68%	4.3分
94	金城医药	0.46%	-2.52%	4.9分
95	奥锐特	0.46%	-3.56%	4.7分
96	华润双鹤	0.44%	-0.50%	5.5分
97	一品红	0.38%	-2.58%	4.7分
98	诚意药业	0.28%	-1.77%	4.2分
99	东诚药业	0.16%	0.16%	5.7分
100	国邦医药	0.13%	0.07%	4.2分
101	百济神州	0.03%	-3.81%	4.9分
102	-	0.00%	-0.81%	分
103	博瑞医药	-0.14%	-2.77%	4.5分
104	康芝药业	-0.45%	-3.38%	4.8分
105	健友股份	-0.50%	-4.13%	4.3分
106	辰欣药业	-0.61%	-1.22%	4.3分
107	司太立	-0.68%	-3.94%	3.8分
108	华特达因	-0.99%	1.01%	4.4分
109	海正药业	-1.09%	-4.69%	5.1分
110	国药现代	-1.17%	-1.74%	4.8分
111	华北制药	-1.26%	-5.05%	5.0分
112	华东医药	-1.29%	-0.79%	5.6分
113	昂利康	-1.36%	-2.05%	4.1分
114	新天地	-1.37%	-3.35%	4.8分
115	广生堂	-1.48%	-4.13%	4.4分
116	苑东生物	-1.49%	1.53%	4.9分
117	科伦药业	-1.62%	-1.09%	5.3分
118	力生制药	-1.75%	-1.47%	4.5分
119	复星医药	-2.11%	-2.66%	5.4分
120	华海药业	-2.13%	-3.19%	5.2分
121	易明医药	-2.15%	2.36%	5.3分
122	-	-2.30%	0.00%	分
123	-	-2.36%	-1.20%	分
124	拓新药业	-2.62%	-5.34%	4.1分
125	纳微科技	-3.10%	-5.98%	4.1分
126	圣诺生物	-3.56%	-1.53%	5.2分
127	亿帆医药	-3.78%	-4.36%	4.5分
128	通化金马	-4.10%	0.06%	5.2分
129	川宁生物	-4.11%	-5.08%	4.1分
130	千红制药	-4.37%	-3.10%	5.0分
131	罗欣药业	-5.35%	-7.54%	4.6分
132	溢多利	-5.96%	-10.24%	4.1分
133	福元医药	-6.01%	-1.65%	4.6分
134	海创药业	-6.09%	-5.93%	4.6分
135	海辰药业	-6.42%	-4.52%	3.9分
136	泰恩康	-6.51%	-4.56%	5.1分
137	微芯生物	-6.68%	-3.44%	4.8分
138	京新药业	-6.81%	-4.00%	5.3分
139	信立泰	-7.03%	-2.72%	5.3分
140	新华制药	-7.49%	-1.71%	5.0分
141	兴齐眼药	-7.56%	-8.50%	5.2分
142	石药景峰	-7.91%	-5.41%	4.8分
143	前沿生物	-8.70%	-10.86%	4.4分
144	灵康药业	-8.83%	-3.42%	4.9分
145	健康元	-8.89%	-1.72%	5.2分
146	宏源药业	-9.18%	-13.56%	4.0分
147	常山药业	-9.35%	-4.60%	4.3分
148	津药药业	-10.75%	-8.25%	4.8分
149	共同药业	-10.98%	-5.39%	4.6分
150	联环药业	-11.07%	-3.85%	5.2分
151	丽珠集团	-11.68%	1.29%	5.3分
152	恒瑞医药	-11.80%	-3.47%	5.3分
153	舒泰神	-12.01%	-3.88%	4.8分
154	百利天恒	-12.14%	-2.46%	4.8分
155	新和成	-12.25%	-0.89%	4.8分
156	奥赛康	-12.92%	-8.54%	4.4分
157	海南海药	-16.07%	-2.77%	3.9分
158	贝达药业	-19.94%	-4.51%	4.3分

<上一页 1 2 3 4 5...27 下一页>

行业评级

研究机构	评级日期	最新评级	上次评级
暂无相关评级

基本面诊股

诊断结果：5.8基本面打败了50%的股票连续3年业绩增长30%的公司

该公司运营状况良好，多数机构认为该股长期投资价值一般。

个股深一度

潜在高分红能力：弱（80分）

基本面得分最高的股票

[ 截止日期：2026-06-30 ]公司经营

盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 94/215 ， 123/215。

[{"date":"2026-06-30","value":"1.72","vol":"-0.16"},{"date":"2026-03-31","value":"0.20","vol":"0.45"},{"date":"2025-12-31","value":"-4.06","vol":"-1.85"},{"date":"2025-09-30","value":"-3.84","vol":"1.60"},{"date":"2025-06-30","value":"-2.91","vol":"1.26"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
净资产收益率(%)	1.72	0.20	-4.06	-3.84	-2.91
行业(%)	-0.16	0.45	-1.85	1.60	1.26

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2026-06-30","value":"25.43","vol":"49.70"},{"date":"2026-03-31","value":"22.08","vol":"50.98"},{"date":"2025-12-31","value":"15.00","vol":"49.96"},{"date":"2025-09-30","value":"12.53","vol":"49.79"},{"date":"2025-06-30","value":"12.01","vol":"49.69"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
销售毛利率(%)	25.43	22.08	15.00	12.53	12.01
行业(%)	49.70	50.98	49.96	49.79	49.69

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 28/215 ， 19/215。

[{"date":"2026-06-30","value":"20.67","vol":"20.52"},{"date":"2026-03-31","value":"26.24","vol":"24.44"},{"date":"2025-12-31","value":"4.77","vol":"38.58"},{"date":"2025-09-30","value":"-2.07","vol":"142.64"},{"date":"2025-06-30","value":"-10.39","vol":"79.18"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
营业收入同比增长率(%)	20.67	26.24	4.77	-2.07	-10.39
行业(%)	20.52	24.44	38.58	142.64	79.18

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2026-06-30","value":"157.37","vol":"371.05"},{"date":"2026-03-31","value":"113.15","vol":"52.58"},{"date":"2025-12-31","value":"17.60","vol":"-24.51"},{"date":"2025-09-30","value":"-570.46","vol":"3.72"},{"date":"2025-06-30","value":"-498.80","vol":"66.32"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
净利润同比增长率(%)	157.37	113.15	17.60	-570.46	-498.80
行业(%)	371.05	52.58	-24.51	3.72	66.32

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 63/215 ， 90/215。

[{"date":"2026-06-30","value":"0.21","vol":"0.21"},{"date":"2026-03-31","value":"0.11","vol":"0.10"},{"date":"2025-12-31","value":"0.34","vol":"0.41"},{"date":"2025-09-30","value":"0.25","vol":"0.31"},{"date":"2025-06-30","value":"0.17","vol":"0.21"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
总资产周转率(次)	0.21	0.11	0.34	0.25	0.17
行业(次)	0.21	0.10	0.41	0.31	0.21

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2026-06-30","value":"0.98","vol":"1.27"},{"date":"2026-03-31","value":"0.59","vol":"0.64"},{"date":"2025-12-31","value":"1.54","vol":"2.56"},{"date":"2025-09-30","value":"1.15","vol":"1.94"},{"date":"2025-06-30","value":"0.77","vol":"1.30"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
存货增长率(次)	0.98	0.59	1.54	1.15	0.77
行业(次)	1.27	0.64	2.56	1.94	1.30

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 30/215 ， 36/215。

[{"date":"2026-06-30","value":"31.61","vol":"4.52"},{"date":"2026-03-31","value":"9.37","vol":"-2.75"},{"date":"2025-12-31","value":"30.16","vol":"16.48"},{"date":"2025-09-30","value":"6.27","vol":"4.59"},{"date":"2025-06-30","value":"29.43","vol":"2.93"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
现金流量净额/营业收入	31.61	9.37	30.16	6.27	29.43
行业	4.52	-2.75	16.48	4.59	2.93

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2026-06-30","value":"0.42","vol":"1.32"},{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.47","vol":"1.60"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.29","vol":"1.72"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
资本支出／折旧和摊销	0.42	-	0.47	-	0.29
行业	1.32	0.00	1.60	0.00	1.72

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 62/215 ， 28/215。

[{"date":"2026-06-30","value":"1.26","vol":"3.49"},{"date":"2026-03-31","value":"1.27","vol":"3.58"},{"date":"2025-12-31","value":"1.28","vol":"3.33"},{"date":"2025-09-30","value":"1.21","vol":"3.50"},{"date":"2025-06-30","value":"1.23","vol":"3.68"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
流动比率	1.26	1.27	1.28	1.21	1.23
行业	3.49	3.58	3.33	3.50	3.68

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2026-06-30","value":"0.77","vol":"2.80"},{"date":"2026-03-31","value":"0.84","vol":"2.94"},{"date":"2025-12-31","value":"0.78","vol":"2.71"},{"date":"2025-09-30","value":"0.69","vol":"2.75"},{"date":"2025-06-30","value":"0.69","vol":"2.90"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
速动比率	0.77	0.84	0.78	0.69	0.69
行业	2.80	2.94	2.71	2.75	2.90

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 39/215 ， 51/215。

[{"date":"2026-06-30","value":"39.22","vol":"33.54"},{"date":"2026-03-31","value":"38.56","vol":"33.40"},{"date":"2025-12-31","value":"39.21","vol":"34.57"},{"date":"2025-09-30","value":"37.15","vol":"34.00"},{"date":"2025-06-30","value":"37.66","vol":"34.11"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
资产负债率(%)	39.22	38.56	39.21	37.15	37.66
行业(%)	33.54	33.40	34.57	34.00	34.11

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2026-06-30","value":"0.66","vol":"0.71"},{"date":"2026-03-31","value":"0.64","vol":"9.83"},{"date":"2025-12-31","value":"0.66","vol":"1.77"},{"date":"2025-09-30","value":"0.60","vol":"1.19"},{"date":"2025-06-30","value":"0.62","vol":"0.88"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
产权比率 (%)	0.66	0.64	0.66	0.60	0.62
行业(%)	0.71	9.83	1.77	1.19	0.88

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构对该股票关注较少，无任何评级。

研究机构	评级日期	最新评级	上次评级
暂无数据

机构预测

暂时还没有机构预测该股2026年的收益，请投资者后续关注。

[{"date":"2022","yellowRectValue":"0.42","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"0.46","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-0.89","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"-0.73","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]

[赛托生物]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]